无感觉 发表于 2025-3-21 17:33:23
书目名称Drugs between Research and Regulations影响因子(影响力)<br> http://impactfactor.cn/if/?ISSN=BK0283216<br><br> <br><br>书目名称Drugs between Research and Regulations影响因子(影响力)学科排名<br> http://impactfactor.cn/ifr/?ISSN=BK0283216<br><br> <br><br>书目名称Drugs between Research and Regulations网络公开度<br> http://impactfactor.cn/at/?ISSN=BK0283216<br><br> <br><br>书目名称Drugs between Research and Regulations网络公开度学科排名<br> http://impactfactor.cn/atr/?ISSN=BK0283216<br><br> <br><br>书目名称Drugs between Research and Regulations被引频次<br> http://impactfactor.cn/tc/?ISSN=BK0283216<br><br> <br><br>书目名称Drugs between Research and Regulations被引频次学科排名<br> http://impactfactor.cn/tcr/?ISSN=BK0283216<br><br> <br><br>书目名称Drugs between Research and Regulations年度引用<br> http://impactfactor.cn/ii/?ISSN=BK0283216<br><br> <br><br>书目名称Drugs between Research and Regulations年度引用学科排名<br> http://impactfactor.cn/iir/?ISSN=BK0283216<br><br> <br><br>书目名称Drugs between Research and Regulations读者反馈<br> http://impactfactor.cn/5y/?ISSN=BK0283216<br><br> <br><br>书目名称Drugs between Research and Regulations读者反馈学科排名<br> http://impactfactor.cn/5yr/?ISSN=BK0283216<br><br> <br><br>合同 发表于 2025-3-21 21:49:14
http://reply.papertrans.cn/29/2833/283216/283216_2.png过分自信 发表于 2025-3-22 02:17:54
http://reply.papertrans.cn/29/2833/283216/283216_3.pnginculpate 发表于 2025-3-22 08:09:33
http://reply.papertrans.cn/29/2833/283216/283216_4.pngObligatory 发表于 2025-3-22 09:30:00
els in 1978 (,Pharmaceutical Medicine - the Future‘) and Paris in 1981 (‘Drug Safety -;- Progress and Controversies‘). This 5th meeting discussed improvements in drug development and application and examined the impact of regulatory activities.978-3-642-54132-2978-3-642-54130-8CONE 发表于 2025-3-22 14:19:26
http://reply.papertrans.cn/29/2833/283216/283216_6.pngCONE 发表于 2025-3-22 17:33:18
http://reply.papertrans.cn/29/2833/283216/283216_7.pngCytokines 发表于 2025-3-23 00:03:13
http://reply.papertrans.cn/29/2833/283216/283216_8.pngLANCE 发表于 2025-3-23 03:57:50
The need of clinical drug trials in children be responsible for this “therapeutic orphan” situation of the child and these include the ignorance and indifference of drug manufacturers and pediatricians, a negative public attitude towards clinical research in general and an uncertainty in the legal and ethical requirements for drug testing in不出名 发表于 2025-3-23 07:43:13
Outro,cceed, now and again, in thwarting their deliberations and obscuring their aims. The issue of Guidelines for the Clinical Investigation of Drugs is a case in point. They are hailed by some and condemned by others and nine tenths of the problem is that the one party really has little idea what the other party is talking about.